Becton Dickinson and Company (BDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Becton Dickinson and Company (BDX) has a cash flow conversion efficiency ratio of 0.027x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($652.00 Million) by net assets ($24.42 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BDX market cap for the company's overall valuation and market capitalisation.
Becton Dickinson and Company - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Becton Dickinson and Company's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Becton Dickinson and Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Becton Dickinson and Company ranked by their cash flow conversion efficiency. Explore Becton Dickinson and Company cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hindustan Unilever Limited
NSE:HINDUNILVR
|
0.128x |
|
Roche Holding AG
SW:RO
|
0.195x |
|
Ciena Corp
NYSE:CIEN
|
0.090x |
|
Sandvik AB
ST:SAND
|
0.046x |
|
Nasdaq Inc
NASDAQ:NDAQ
|
0.051x |
|
Unimicron Technology Corp
TW:3037
|
0.050x |
|
Swedbank AB (publ)
ST:SWED-A
|
-0.020x |
|
MERCEDES-BENZ GRP ADR/1/4
F:DAII
|
0.029x |
Annual Cash Flow Conversion Efficiency for Becton Dickinson and Company (1989–2025)
The table below shows the annual cash flow conversion efficiency of Becton Dickinson and Company from 1989 to 2025. View Becton Dickinson and Company (BDX) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $25.39 Billion | $3.43 Billion | 0.135x | -7.91% |
| 2024-09-30 | $25.89 Billion | $3.80 Billion | 0.147x | +26.61% |
| 2023-09-30 | $25.80 Billion | $2.99 Billion | 0.116x | +11.25% |
| 2022-09-30 | $25.28 Billion | $2.63 Billion | 0.104x | -46.94% |
| 2021-09-30 | $23.68 Billion | $4.65 Billion | 0.196x | +31.80% |
| 2020-09-30 | $23.77 Billion | $3.54 Billion | 0.149x | -5.38% |
| 2019-09-30 | $21.16 Billion | $3.33 Billion | 0.157x | +15.32% |
| 2018-09-30 | $20.99 Billion | $2.87 Billion | 0.136x | -30.71% |
| 2017-09-30 | $12.95 Billion | $2.55 Billion | 0.197x | -41.25% |
| 2016-09-30 | $7.63 Billion | $2.56 Billion | 0.335x | +45.54% |
| 2015-09-30 | $7.51 Billion | $1.73 Billion | 0.230x | -33.27% |
| 2014-09-30 | $5.05 Billion | $1.74 Billion | 0.345x | +15.47% |
| 2013-09-30 | $5.04 Billion | $1.51 Billion | 0.299x | -29.77% |
| 2012-09-30 | $4.14 Billion | $1.76 Billion | 0.426x | +19.75% |
| 2011-09-30 | $4.83 Billion | $1.72 Billion | 0.355x | +10.74% |
| 2010-09-30 | $5.43 Billion | $1.74 Billion | 0.321x | -3.86% |
| 2009-09-30 | $5.14 Billion | $1.72 Billion | 0.334x | -2.34% |
| 2008-09-30 | $4.94 Billion | $1.69 Billion | 0.342x | +20.20% |
| 2007-09-30 | $4.36 Billion | $1.24 Billion | 0.284x | +1.35% |
| 2006-09-30 | $3.84 Billion | $1.08 Billion | 0.281x | -26.24% |
| 2005-09-30 | $3.22 Billion | $1.23 Billion | 0.380x | +6.34% |
| 2004-09-30 | $3.07 Billion | $1.10 Billion | 0.358x | +14.43% |
| 2003-09-30 | $2.90 Billion | $905.70 Million | 0.313x | -6.96% |
| 2002-09-30 | $2.49 Billion | $836.03 Million | 0.336x | +0.50% |
| 2001-09-30 | $2.33 Billion | $778.64 Million | 0.334x | +6.26% |
| 2000-09-30 | $1.96 Billion | $615.49 Million | 0.315x | +28.89% |
| 1999-09-30 | $1.77 Billion | $431.80 Million | 0.244x | -21.33% |
| 1998-09-30 | $1.61 Billion | $500.80 Million | 0.310x | -2.89% |
| 1997-09-30 | $1.39 Billion | $442.70 Million | 0.320x | -8.02% |
| 1996-09-30 | $1.33 Billion | $460.40 Million | 0.347x | +2.89% |
| 1995-09-30 | $1.40 Billion | $472.20 Million | 0.338x | +4.34% |
| 1994-09-30 | $1.48 Billion | $479.50 Million | 0.324x | +47.43% |
| 1993-09-30 | $1.46 Billion | $319.80 Million | 0.220x | +13.59% |
| 1992-09-30 | $1.59 Billion | $308.20 Million | 0.193x | +3.72% |
| 1991-09-30 | $1.36 Billion | $254.10 Million | 0.186x | -11.26% |
| 1990-09-30 | $1.23 Billion | $259.00 Million | 0.210x | +53.14% |
| 1989-09-30 | $1.07 Billion | $146.90 Million | 0.137x | -- |
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more